Wed. Nov 13th, 2024

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial | Psychiatry and Behavioral Health | JAMA Psychiatry | JAMA Network

Bydashephe

Nov 1, 2024

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2818047

By dashephe

Related Post

Novel Drug Improves Depression, Insomnia Symptoms as Add-On Therapy | MedPage Today

Nov 7, 2024 dashephe

Abx Stewardship Education Infxn Control Internal Med Uncategorized

Antibiotic Stewardship – Antibiotic awareness week Nov 18-24, 2024; FOR PROVIDERS.

Nov 4, 2024 dashephe

Stroke Survivors Still Prescribed a ‘Concerning’ Amount of Benzos | MedPage Today

Nov 1, 2024 dashephe

You missed

Novel Drug Improves Depression, Insomnia Symptoms as Add-On Therapy | MedPage Today

November 7, 2024 dashephe

Abx Stewardship Education Infxn Control Internal Med Uncategorized

Antibiotic Stewardship – Antibiotic awareness week Nov 18-24, 2024; FOR PROVIDERS.

November 4, 2024 dashephe

AHA/ACC 2022 HF Guidelines

November 4, 2024 dashephe

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial | Psychiatry and Behavioral Health | JAMA Psychiatry | JAMA Network

November 1, 2024 dashephe